We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ingersoll Rand Gains From Business Strength Amid Persisting Headwinds
Read MoreHide Full Article
Key Takeaways
IR's IT&S orders rose 9% to $1.55B in Q4 2025, while Precision & Science orders grew 6.5%.
IR completed multiple 2025 acquisitions, adding 4% to Q4 revenues and boosting portfolios.
IR's cost of sales rose 6.1% in 2025, with FX and global exposure posing added risks.
Ingersoll Rand Inc. (IR - Free Report) is poised to gain from the exposure to various end markets, including industrial manufacturing, mining & construction, energy, transportation, medical and laboratory sciences, food and beverage packaging, as well as chemical processing. The company continues to see higher orders across its product portfolio of industrial vacuums and blowers, power tools and compressors, which will drive the Industrial Technologies & Services (IT&S) segment. The segment’s order totaled $1.55 billion, up 9% year over year in the fourth quarter of 2025.
Strong momentum in the life sciences business, driven by growth in fluid handling product orders within the legacy Gardner Denver Medical platform, is likely to be a tailwind for the Precision and Science Technologies segment. Strength in the precision technologies business and an increase in demand for biopharma solutions also bode well. The segment reported an order of $402.2 million in the fourth quarter, up 6.5% year over year.
Ingersoll Rand believes in expanding its market presence, solidifying its customer base and enhancing product offerings through acquisitions. In the fourth quarter of 2025, acquisitions contributed 4% to total revenues. In November 2025, it acquired Transvac Systems Ltd., which enhanced Ingersoll Rand’s portfolio of engineered solutions with advanced ejector and hybrid systems. Transvac is incorporated into the company’s Industrial Technologies and Services segment. In August 2025, IR acquired Dave Barry Plastics, which boosted its life science portfolio. Dave Barry Plastics is incorporated into Ingersoll Rand’s Precision and Science Technologies segment.
In June 2025, the company acquired Lead Fluid (Baoding) Intelligent Equipment Manufacturing Co., Ltd (Lead Fluid), which boosted its life science business in China. Lead Fluid is incorporated into the Precision and Science Technologies segment. In April 2025, Ingersoll completed the acquisition of G & D Chillers, Inc. (G&D) and Advanced Gas Technologies Inc. (“AGT”). The acquisitions expanded the company’s air treatment portfolio. The acquired companies are incorporated into the Industrial Technologies & Services segment. In February 2025, the company acquired SSI Aeration, Inc. (“SSI”), which enhanced its ability to offer integrated low-pressure compressor and aeration solutions. SSI is incorporated into its IT&S segment.
IR’s commitment to rewarding shareholders through dividends and share buybacks is encouraging. In 2025, the company paid out dividends of $31.8 million and repurchased treasury stocks worth $1.02 billion. In April 2024, the company’s board of directors approved a $1 billion increase to the share repurchase authorization. Also, in May 2025, Ingersoll Rand’s board of directors authorized an additional $1 billion increase to its existing share repurchase program. This is in addition to the company’s previous share repurchase program.
However, cost inflation is weighing on Ingersoll Rand’s operations. The company’s cost of sales increased 6.1% year over year in 2025, due to the increasing cost of raw materials and component parts. Ingersoll Rand’s selling and administrative expenses rose 7.1% year over year in 2025. The selling and administrative expenses, as a percentage of revenues, increased 20 basis points to 18.8%. The company has been witnessing high costs associated with investments to support growth in areas like demand generation, digital and other IT-related investments. It expects to incur corporate costs of approximately $170 million in 2026.
IR has considerable exposure to regions outside the United States. Its significant international presence exposes it to political and economic disruptions, all of which can directly affect its profits. Also, the company is exposed to headwinds arising from unfavorable movements in foreign currencies.
View the Zacks #1 Rank List
Image: Bigstock
Ingersoll Rand Gains From Business Strength Amid Persisting Headwinds
Key Takeaways
Ingersoll Rand Inc. (IR - Free Report) is poised to gain from the exposure to various end markets, including industrial manufacturing, mining & construction, energy, transportation, medical and laboratory sciences, food and beverage packaging, as well as chemical processing. The company continues to see higher orders across its product portfolio of industrial vacuums and blowers, power tools and compressors, which will drive the Industrial Technologies & Services (IT&S) segment. The segment’s order totaled $1.55 billion, up 9% year over year in the fourth quarter of 2025.
Strong momentum in the life sciences business, driven by growth in fluid handling product orders within the legacy Gardner Denver Medical platform, is likely to be a tailwind for the Precision and Science Technologies segment. Strength in the precision technologies business and an increase in demand for biopharma solutions also bode well. The segment reported an order of $402.2 million in the fourth quarter, up 6.5% year over year.
Ingersoll Rand believes in expanding its market presence, solidifying its customer base and enhancing product offerings through acquisitions. In the fourth quarter of 2025, acquisitions contributed 4% to total revenues. In November 2025, it acquired Transvac Systems Ltd., which enhanced Ingersoll Rand’s portfolio of engineered solutions with advanced ejector and hybrid systems. Transvac is incorporated into the company’s Industrial Technologies and Services segment. In August 2025, IR acquired Dave Barry Plastics, which boosted its life science portfolio. Dave Barry Plastics is incorporated into Ingersoll Rand’s Precision and Science Technologies segment.
In June 2025, the company acquired Lead Fluid (Baoding) Intelligent Equipment Manufacturing Co., Ltd (Lead Fluid), which boosted its life science business in China. Lead Fluid is incorporated into the Precision and Science Technologies segment. In April 2025, Ingersoll completed the acquisition of G & D Chillers, Inc. (G&D) and Advanced Gas Technologies Inc. (“AGT”). The acquisitions expanded the company’s air treatment portfolio. The acquired companies are incorporated into the Industrial Technologies & Services segment. In February 2025, the company acquired SSI Aeration, Inc. (“SSI”), which enhanced its ability to offer integrated low-pressure compressor and aeration solutions. SSI is incorporated into its IT&S segment.
IR’s commitment to rewarding shareholders through dividends and share buybacks is encouraging. In 2025, the company paid out dividends of $31.8 million and repurchased treasury stocks worth $1.02 billion. In April 2024, the company’s board of directors approved a $1 billion increase to the share repurchase authorization. Also, in May 2025, Ingersoll Rand’s board of directors authorized an additional $1 billion increase to its existing share repurchase program. This is in addition to the company’s previous share repurchase program.
However, cost inflation is weighing on Ingersoll Rand’s operations. The company’s cost of sales increased 6.1% year over year in 2025, due to the increasing cost of raw materials and component parts. Ingersoll Rand’s selling and administrative expenses rose 7.1% year over year in 2025. The selling and administrative expenses, as a percentage of revenues, increased 20 basis points to 18.8%. The company has been witnessing high costs associated with investments to support growth in areas like demand generation, digital and other IT-related investments. It expects to incur corporate costs of approximately $170 million in 2026.
IR has considerable exposure to regions outside the United States. Its significant international presence exposes it to political and economic disruptions, all of which can directly affect its profits. Also, the company is exposed to headwinds arising from unfavorable movements in foreign currencies.
Ingersoll Rand, which belongs to the Manufacturing - General Industrial industry, faces stiff competition from peers like Gates Industrial Corporation plc (GTES - Free Report) , Helios Technologies, Inc. (HLIO - Free Report) and Crane Company (CR - Free Report) .